301 related articles for article (PubMed ID: 7526119)
1. Expression of meningococcal epitopes in LamB of Escherichia coli and the stimulation of serosubtype-specific antibody responses.
McCarvil J; McKenna AJ; Grief C; Hoy CS; Sesardic D; Maiden MC; Feavers IM
Mol Microbiol; 1993 Oct; 10(1):203-13. PubMed ID: 7526119
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease.
Idänpään-Heikkilä I; Høiby EA; Chattopadhyay P; Airaksinen U; Michaelsen TM; Wedege E
J Med Microbiol; 1995 Nov; 43(5):335-43. PubMed ID: 7562997
[TBL] [Abstract][Full Text] [Related]
3. Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.
McGuinness B; Barlow AK; Clarke IN; Farley JE; Anilionis A; Poolman JT; Heckels JE
J Exp Med; 1990 Jun; 171(6):1871-82. PubMed ID: 1693651
[TBL] [Abstract][Full Text] [Related]
4. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.
van der Voort ER; van der Ley P; van der Biezen J; George S; Tunnela O; van Dijken H; Kuipers B; Poolman J
Infect Immun; 1996 Jul; 64(7):2745-51. PubMed ID: 8698504
[TBL] [Abstract][Full Text] [Related]
5. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine.
Martin SL; Borrow R; van der Ley P; Dawson M; Fox AJ; Cartwright KA
Vaccine; 2000 May; 18(23):2476-81. PubMed ID: 10775781
[TBL] [Abstract][Full Text] [Related]
6. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide.
Christodoulides M; McGuinness BT; Heckels JE
J Gen Microbiol; 1993 Aug; 139(8):1729-38. PubMed ID: 7691983
[TBL] [Abstract][Full Text] [Related]
7. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.
van der Ley P; van der Biezen J; Hohenstein P; Peeters C; Poolman JT
Infect Immun; 1993 Oct; 61(10):4217-24. PubMed ID: 7691745
[TBL] [Abstract][Full Text] [Related]
8. Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis.
Christodoulides M; Heckels JE
Microbiology (Reading); 1994 Nov; 140 ( Pt 11)():2951-60. PubMed ID: 7529096
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design.
Suker J; Feavers IM; Maiden MCJ
Microbiology (Reading); 1996 Jan; 142 ( Pt 1)():63-69. PubMed ID: 8581171
[TBL] [Abstract][Full Text] [Related]
10. Stable expression of meningococcal class 1 protein in an antigenically reactive form in outer membranes of Escherichia coli.
White DA; Barlow AK; Clarke IN; Heckels JE
Mol Microbiol; 1990 May; 4(5):769-76. PubMed ID: 2117694
[TBL] [Abstract][Full Text] [Related]
11. The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.
Martin DR; Ruijne N; McCallum L; O'Hallahan J; Oster P
Clin Vaccine Immunol; 2006 Apr; 13(4):486-91. PubMed ID: 16603616
[TBL] [Abstract][Full Text] [Related]
12. Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis.
Wright JC; Williams JN; Christodoulides M; Heckels JE
Infect Immun; 2002 Aug; 70(8):4028-34. PubMed ID: 12117908
[TBL] [Abstract][Full Text] [Related]
13. A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine.
Delvig AA; Wedege E; Caugant DA; Dalseg R; Kolberg J; Achtman M; Rosenqvist E
Microbiology (Reading); 1995 Jul; 141 ( Pt 7)():1593-600. PubMed ID: 7551027
[TBL] [Abstract][Full Text] [Related]
14. Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines.
Rouppe van der Voort EM; Kuipers B; Brugghe HF; van Unen LM; Timmermans HA; Hoogerhout P; Poolman JT
FEMS Immunol Med Microbiol; 1997 Mar; 17(3):139-48. PubMed ID: 9093834
[TBL] [Abstract][Full Text] [Related]
15. Identification of variable region differences in Neisseria meningitidis class 3 protein sequences among five group B serotypes.
Zapata GA; Vann WF; Rubinstein Y; Frasch CE
Mol Microbiol; 1992 Dec; 6(23):3493-9. PubMed ID: 1335540
[TBL] [Abstract][Full Text] [Related]
16. Neisseria meningitidis antigen NMB0088: sequence variability, protein topology and vaccine potential.
Sardiñas G; Yero D; Climent Y; Caballero E; Cobas K; Niebla O
J Med Microbiol; 2009 Feb; 58(Pt 2):196-208. PubMed ID: 19141737
[TBL] [Abstract][Full Text] [Related]
17. A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis.
Granoff DM; Moe GR; Giuliani MM; Adu-Bobie J; Santini L; Brunelli B; Piccinetti F; Zuno-Mitchell P; Lee SS; Neri P; Bracci L; Lozzi L; Rappuoli R
J Immunol; 2001 Dec; 167(11):6487-96. PubMed ID: 11714816
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of viral B-cell epitopes inserted into two surface loops of the Escherichia coli K12 LamB protein and expressed in an attenuated aroA strain of Salmonella typhimurium.
Wang J; Michel V; Leclerc C; Hofnung M; Charbit A
Vaccine; 1999 Jan; 17(1):1-12. PubMed ID: 10078601
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide.
van den Elsen JM; Herron JN; Hoogerhout P; Poolman JT; Boel E; Logtenberg T; Wilting J; Crommelin DJ; Kroon J; Gros P
Proteins; 1997 Sep; 29(1):113-25. PubMed ID: 9294871
[TBL] [Abstract][Full Text] [Related]
20. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design.
Feavers IM; Fox AJ; Gray S; Jones DM; Maiden MC
Clin Diagn Lab Immunol; 1996 Jul; 3(4):444-50. PubMed ID: 8807211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
